UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
Aryl hydrocarbon receptor and bilirubin as therapeutic target for ICH
Aryl hydrocarbon receptor and bilirubin as therapeutic target for ICH is a funding opportunity from UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, up to 471323, closing May 31, 2027.
May 31, 2027
(304d left)Overview
After intracerebral hemorrhage (ICH), phago(endo)cytosis of hematoma components [erythrocytes (RBC), hemoglobin (Hb) and heme], by microglia/macrophages (MMΦ) is essential for removal/detoxification of the hematoma, resolution of inflammation, and restoration of brain homeostasis for optimal neurological recovery.…